OBJECTIVE: We compared the effects of a low glycemic index (GI) diet with the American Diabetes Association (ADA) diet on glycosylated hemoglobin (HbA1c) among individuals with type 2 diabetes. METHODS:Forty individuals with poorly controlled type 2 diabetes were randomized to a low-GI or an ADA diet. The intervention, consisting of eight educational sessions (monthly for the first 6 mo and then at months 8 and 10), focused on a low-GI or an ADA diet. Data on demographics, diet, physical activity, psychosocial factors, and diabetes medication use were assessed at baseline and 6 and 12 mo. Generalized linear mixed models were used to compare the two groups on HbA1c, diabetic medication use, blood lipids, weight, diet, and physical activity. RESULTS:Participants (53% female, mean age 53.5 y) were predominantly white with a mean body mass index of 35.8 kg/m(2). Although both interventions achieved similar reductions in mean HbA1c at 6 mo and 12 mo, the low-GI diet group was less likely to add or increase dosage of diabetic medications (odds ratio 0.26, P = 0.01). Improvements in high-density lipoprotein cholesterol, triacylglycerols, and weight loss were similar between groups. CONCLUSION: Compared with the ADA diet, the low-GI diet achieved equivalent control of HbA1c using less diabetic medication. Despite its limited size, this trial suggests that a low-GI diet is a viable alternative to the ADA diet. Findings should be evaluated in a larger randomized controlled trial.
RCT Entities:
OBJECTIVE: We compared the effects of a low glycemic index (GI) diet with the American Diabetes Association (ADA) diet on glycosylated hemoglobin (HbA1c) among individuals with type 2 diabetes. METHODS: Forty individuals with poorly controlled type 2 diabetes were randomized to a low-GI or an ADA diet. The intervention, consisting of eight educational sessions (monthly for the first 6 mo and then at months 8 and 10), focused on a low-GI or an ADA diet. Data on demographics, diet, physical activity, psychosocial factors, and diabetes medication use were assessed at baseline and 6 and 12 mo. Generalized linear mixed models were used to compare the two groups on HbA1c, diabetic medication use, blood lipids, weight, diet, and physical activity. RESULTS:Participants (53% female, mean age 53.5 y) were predominantly white with a mean body mass index of 35.8 kg/m(2). Although both interventions achieved similar reductions in mean HbA1c at 6 mo and 12 mo, the low-GI diet group was less likely to add or increase dosage of diabetic medications (odds ratio 0.26, P = 0.01). Improvements in high-density lipoprotein cholesterol, triacylglycerols, and weight loss were similar between groups. CONCLUSION: Compared with the ADA diet, the low-GI diet achieved equivalent control of HbA1c using less diabetic medication. Despite its limited size, this trial suggests that a low-GI diet is a viable alternative to the ADA diet. Findings should be evaluated in a larger randomized controlled trial.
Authors: David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman Journal: N Engl J Med Date: 2005-12-22 Impact factor: 91.245
Authors: Ivan Zador; Laurie J Meyer; Dawn R Scheets; Thorne M Wittstruck; Tammi Timmler; Dolores M Switaj Journal: Acta Paediatr Date: 2006-01 Impact factor: 2.299
Authors: Y Ma; B C Olendzki; W Li; A R Hafner; D Chiriboga; J R Hebert; M Campbell; M Sarnie; I S Ockene Journal: Eur J Clin Nutr Date: 2006-04 Impact factor: 4.016
Authors: Yunsheng Ma; Barbara C Olendzki; Andrea R Hafner; David E Chiriboga; Annie L Culver; Victoria A Andersen; Philip A Merriam; Sherry L Pagoto Journal: Nutrition Date: 2006-10-04 Impact factor: 4.008
Authors: Y Ma; B C Olendzki; D Chiriboga; M Rosal; E Sinagra; S Crawford; A R Hafner; S L Pagoto; R P Magner; I S Ockene Journal: Eur J Clin Nutr Date: 2006-05-17 Impact factor: 4.016
Authors: D J Jenkins; T M Wolever; R H Taylor; H Barker; H Fielden; J M Baldwin; A C Bowling; H C Newman; A L Jenkins; D V Goff Journal: Am J Clin Nutr Date: 1981-03 Impact factor: 7.045
Authors: Peterson Karolina; Rudolf Chlup; Zapletalova Jana; Klaus Dieter Kohnert; Pavla Kudlova; Josef Bartek; Marie Nakladalova; Blanka Doubravova; Pavel Seckar Journal: J Diabetes Sci Technol Date: 2010-07-01
Authors: J L Sievenpiper; C W C Kendall; A Esfahani; J M W Wong; A J Carleton; H Y Jiang; R P Bazinet; E Vidgen; D J A Jenkins Journal: Diabetologia Date: 2009-06-13 Impact factor: 10.122
Authors: Madelyn L Wheeler; Stephanie A Dunbar; Lindsay M Jaacks; Wahida Karmally; Elizabeth J Mayer-Davis; Judith Wylie-Rosett; William S Yancy Journal: Diabetes Care Date: 2012-02 Impact factor: 19.112